Endpoints News 24 nov. 2025 J&J’s tau-targeting antibody fails Phase 2 Alzheimer's study #fails Phase #Alzheimer study
Endpoints News 21 nov. 2025 Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial #Thursday afternoon #fails Phase